In this study, we investigated the potential roles of ADAM10 and CD58 proteins in acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL), both in their treated and untreated states, by comparing their expression levels to a healthy control group. The gene discussed is ADAM10; the disease is acute lymphoblastic leukemia.